The latest guidelines of the World Health Organization (WHO) on TB treatment, emphasize the importance of digital technologies in supporting the implementation of the End TB Strategy. The guidelines contain the first-ever WHO evidence-based recommendations on the use of phones, video or electronic medication monitors to help patients adhere to TB medication and deliver TB care.
The Member States of the World Health Organization (WHO) elected Dr Tedros Adhanom Ghebreyesus to a five-year term as the new Director-General of the WHO. Dr Tedros is a physician and former Minister of Health and Minister of Foreign Affairs of the Federal Democratic Republic of Ethiopia. The election took place at the Seventieth World Health Assembly in Geneva, Switzerland.
“Dr Tedros is a proven leader who spearheaded massive improvements in Ethiopia’s healthcare system. His work to develop a national cadre of community health workers was a pioneering solution for improving public health that many other countries have since followed,” said José Luis Castro, Executive Director of the International Union Against Tuberculosis and Lung Disease (The Union). “He has the credentials, the diplomatic skills, and the management experience to effectively lead the WHO during one of the most critical moments in its history.”
Read an opinion piece by the Union’s Executive Director, José Luis Castro, on the need for WHO reform
Ethiopia’s former health minister has been elected to serve as the next director-general of the World Health Organization — the first African picked to lead the global health agency. Tedros Adhanom Ghebreyesus will succeed Dr. Margaret Chan on July 1.
WHO Director-General charts progress made in the fight against TB in new report - “Ten years in public health 2007-2017”
WHO today released the chapter on the fight against tuberculosis (TB) in the Director-General’s new report “Ten years in public health 2007-2017”. The report chronicles the evolution of global public health over the decade that Dr. Margaret Chan served as Director-General at WHO.
The chapter highlights the successes and challenges in global efforts to combat TB since 2007, when the fight against TB faced two major crises: a continuing co-epidemic of TB/HIV ravaging Africa and the emergence of more deadly drug resistance strains called XDR-TB or extensively drug-resistant TB. It elaborates the critical role played by WHO and its partners through a culture of innovation, leading to breakthroughs in diagnosis, treatment and the roll-out of a new Strategy to end TB.
The guidelines feature recommendations on important developments in treatment and care which have occurred in the past seven years, since the publication of the previous guidelines.
The World Health Organization just published the first ever Global Hepatitis Report, which notes that the viral hepatitis mortality rate is increasing worldwide, while deaths caused by HIV and tuberculosis continue to drop.
Who Reports Global Burden of Viral Hepatitis is Increasing
The Centers for Disease Control and Prevention (CDC), Division of Tuberculosis Elimination (DTBE) is pleased to announce the release of "Implementing an Electronic Directly Observed Therapy (eDOT) Program: A Toolkit for Tuberculosis (TB) Programs".The purpose of the toolkit is to assist TB programs in developing and implementing an eDOT program. The toolkit provides a general overview of eDOT, steps for implementing a TB eDOT program, and sample forms that can be tailored to fit individual TB program needs.
Access eDOT Toolkit
TB and Depression
April 7, 2017
To coincide with World Health Day, the World Health Organization (WHO) published a Newsflash regarding TB and Depression.
The BCG World Atlas, an interactive map that shows detailed information on current and past BCG policies and practices for over 180 countries, has been updated.
The 2nd Edition of the BCG World Atlas provides user friendly, open access, and easy to access data on the current TB vaccine and provides the clinician, researcher, and public health practitioner alike with resources and information necessary to interpret current and novel TB diagnostics and conduct fruitful research on novel vaccines.
A new education module entitled "Landscape and Language of Molecular Diagnostics for TB Drug Resistance" was developed by and is now available from the Association of Public Health Laboratories and the CDC. This module provides a brief overview of basic principles of molecular biology and test platforms used for molecular testing of Mycobacterium tuberculosis as a basis for understanding how mutations are associated with drug resistance in TB and what reporting language might be used to describe resistance results.
Link to full list of training modules:
Questions about the module can be sent to Stephanie Johnston, MS at email@example.com.